$200 billion deal, page-20

To find a fair price we could also look at recent Pharma Deals

Merck & Co bought out Prometheus for $10.8 billion USD ($17.18 Billion AUD)
picking up a promising experimental treatment for ulcerative colitis and Crohn's disease and building up its presence in immunology.

https://www.reuters.com/markets/dea...cquire-prometheus-biosciences-wsj-2023-04-16/

Ulcerative colitis and Crohn's disease have a combined market of $17.5 Billion a Year.

BIT in comparison can treat much higher Billion a year markets,
So should be valued much higher....IMO....

(Something in the $100 Billion to $200 Billion range seems reasonable.)

Another recent Pharma Purchase was:
In March Pfizer struck a $43 billion USD ($67.65 Billion AUD) deal
to acquire Seagen Inc (SGEN.O) and its targeted cancer therapies.

Anyhow here's a list of Big Pharma Co's by Market Cap:
https://companiesmarketcap.com/pharmaceuticals/largest-pharmaceutical-companies-by-market-cap/

(note: their market Caps are in USD)